Effects of bone marrow‑derived mesenchymal stem cells transfected with survivin on pulmonary fibrosis in mice

Zhou,Mi; Chen,Dong‑Ling; Jiang,Tao; Feng,Yan‑Mei; Han,Xiao‑Li

doi:10.3892/etm.2015.2715

Effects of bone marrow‑derived mesenchymal stem cells transfected with survivin on pulmonary fibrosis in mice

Authors:
- Mi Zhou
- Dong‑Ling Chen
- Tao Jiang
- Yan‑Mei Feng
- Xiao‑Li Han
View Affiliations

Affiliations: Department of Respiratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Yuzhong, Chongqing 400042, P.R. China
Published online on: September 1, 2015 https://doi.org/10.3892/etm.2015.2715
Pages: 1857-1864

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the effects of bone marrow‑derived mesenchymal stem cells (BMSCs) transfected with survivin on lung fibrosis in mice. Mice with bleomycin‑induced pulmonary fibrosis were allocated at random to group A, B or C, and injected with 1x106 survivin gene‑expressing BMSCs, 1x106 BMSCs or normal saline, respectively. A total of 6 mice were sacrificed from each group on days 7, 14 and 28 after treatment. The extent of alveolitis and pulmonary fibrosis was assessed and the apoptotic rates of the BMSCs and survivin‑expressing BMSCs were detected. The content of surfactant protein A (SP‑A) in the lung and hydroxyproline (Hyp) in the serum was measured. The mRNA expression levels of transforming growth factor (TGF)‑β1 and matrix metalloproteinase (MMP)‑9 in the lung tissue of the mice was detected. Furthermore, the protein expression levels of caspase‑3 and ‑9 were detected. The apoptotic rates of the BMSCs (group B) and survivin‑expressing BMSCs (group A) were 14.466±1.953 and 7.718±0.493%, respectively. The degree of lung fibrosis in groups A and B was reduced compared with that in group C. The hydroxyproline content in groups A and B was reduced compared with that in group C, and the SP‑A content in groups A and B was increased compared with that in group C. The mRNA expression levels of TGF‑β1 in group A were reduced compared with those in group B, and the levels in group B were reduced compared with those in group C. By contrast, the mRNA expression levels of MMP‑9 in group A were increased compared with those in groups B and C, and the levels in group B were increased compared with those in group A. The expression levels of caspase‑3 and ‑9 in group A were elevated compared with those in groups B and C. In conclusion, BMSCs are effective in preventing bleomycin‑induced lung fibrosis, and survivin may enhance the protective effects of BMSCs.

View Figures

View References

1	Liu X, Qian L, Nan HY, Cui M, Hao XY and Du YF: Function of the transforming growth factor-β 1/c-Jun N-terminal kinase signaling pathway in the action of thalidomide on a rat model of pulmonary fibrosis. Exp Ther Med. 7:669–674. 2014.PubMed/NCBI
2	Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, Boyd R and Trounson A: Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol. 175:303–313. 2009. View Article : Google Scholar : PubMed/NCBI
3	Selman M, King TE and Pardo A: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 134:136–151. 2001. View Article : Google Scholar : PubMed/NCBI
4	Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddo M, Kaminski N and Phinney DG: Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA. 100:8407–8411. 2003. View Article : Google Scholar : PubMed/NCBI
5	Zhang ZH, Lu Y, Luan Y and Zhao JJ: Effect of bone marrow mesenchymal stem cells on experimental pulmonary arterial hypertension. Exp Ther Med. 4:839–843. 2012.PubMed/NCBI
6	Kondo K, Shintani S, Shibata R, Murakami H, Murakami R, Imaizumi M, Kitagawa Y and Murohara T: Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol. 29:61–66. 2009. View Article : Google Scholar : PubMed/NCBI
7	Tzouvelekis A, Harokopos V, Paparountas T, Oikonomou N, Chatziioannou A, Vilaras G, Tsiambas E, Karameris A, Bouros D and Aidinis V: Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1α in disease pathogenesis. Am J Respir Crit Care Med. 176:1108–1119. 2007. View Article : Google Scholar : PubMed/NCBI
8	Wu Z, Wang X, Yang R, Liu Y, Zhao W, Si J, Ma X, Su C, Liu Y, Tan Y, Liu W, et al: Effects of carbon ion beam irradiation on lung injury and pulmonary fibrosis in mice. Exp Ther Med. 5:771–776. 2013.PubMed/NCBI
9	Sun YW, Li BP, Wang Xuan, Zhang L, Lu PY and Zhao XY: Oriented migration of intravenously administrated mesenchymal stem cells transfected with adenovirus vector mediated green fluorescence protein in the lung tissue of pulmonary emphysema rats. Zhongguo Zu Zhi Gong Cheng Yan Jiu Yu Lin Chuang Kang Fu. 14:2528–2532. 2010.(In Chinese).
10	Cai Y: Pulmonary fibrosis drug treatment progress. Shi Jie Lin Chuang Yao Wu. 29:17–19. 2008.(In Chinese).
11	Liu T, Xie M, Wang HL and Ling W: Effect of matrine and IFN-γ on bleomycin-induced pulmonary fibrosis. Nanjing Yi Ke Da Xue Xue Bao. 28:592–596. 2008.(In Chinese).
12	Bhatt N, Baran C, Allen J, Magro C and Marsh CB: Promising pharmacologic innovations in treating pulmonary fibrosis. Curr Opin Pharmacol. 6:284–292. 2006. View Article : Google Scholar : PubMed/NCBI
13	Lettieri CJ, Veerappan GR, Helman DL, Mulligan CR and Shorr AF: Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest. 127:1600–1605. 2005. View Article : Google Scholar : PubMed/NCBI
14	Hu F: Research progress of Chinese medicine treatment of pulmonary fibrosis. Yi Yao Dao Bao. 11:1471–1474. 2011.(In Chinese).
15	Xu L, Xiao W, Ma DD, Zhou SY and Zhang QH: Ulcerative colitis combined with acute interstitial lung disease and airway disease: A case report and literature review. Exp Ther Med. 8:1229–1236. 2014.PubMed/NCBI
16	Kotton DN, Ma BY, Cardoso WV, Sanderson EA, Summer RS, Williams MC and Fine A: Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development. 128:5181–5188. 2001.PubMed/NCBI
17	Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S and Sharkis SJ: Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 105:369–377. 2001. View Article : Google Scholar : PubMed/NCBI
18	Teke T, Maden E, Kiyici A, Korkmaz C, Gok Z, Ozer F, Imecik O and Uzun K: Cigarette smoke and bleomycin-induced pulmonary oxidative stress in rats. Exp Ther Med. 4:121–124. 2012.PubMed/NCBI
19	Tzouvelekis A, Antoniadis A and Bouros D: Stem cell therapy in pulmonary fibrosis. Curr Opin Pulm Med. 17:368–373. 2011. View Article : Google Scholar : PubMed/NCBI
20	Cui A, Dai HP and Dai JW: Effects of bone marrow mesenchymal stem cells on bleomycin induced pulmonary fibrosis in rats. Zhonghua Jie He He Hu Xi Za Zhi. 30:677–682. 2007.(In Chinese). PubMed/NCBI
21	Rojas M, Xu J, Woods CR, Spears W, Roman J and Brigham KL: Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol. 33:145–152. 2005. View Article : Google Scholar : PubMed/NCBI
22	Beardmore VA, Ahonen LJ, Gorbsky GJ and Kallio MJ: Survivin dynamics increases at centromeres during G2/M phase transition and is regulated by microtubule-attachment and Aurora B kinase activity. J Cell Sci. 117:4033–4042. 2004. View Article : Google Scholar : PubMed/NCBI
23	Yang M, Liu Y, Lu S, Wang Z, Wang R, Zi Y and Li J: Analysis of the expression levels of surviving and VEGF in patients with acute lymphoblastic leukemia. Exp Ther Med. 5:305–307. 2013.PubMed/NCBI
24	Liu F, Liu S, He S, Xie Z, Zu X and Jiang Y: Survivin transcription is associated with P-glycoprotein/MDR1 over expression in the multidrug resistance of MCF-7 breast cancer cells. Oncol Rep. 23:1469–1475. 2010.PubMed/NCBI
25	Chen Y, Ma N, Mei J, Xiao HB, Lu SW, Xu HY and Zhong H: In vitro induction of human bone marrow mesenchymal stem cells to differentiate into type II alveolar epithelial cells. Zhong Guo Zu Zhi Gong Cheng Yan Jiu. 16:1737–1741. 2012.(In Chinese).
26	Guo T, Fang M, Zhang D and Li X: Combination treatment with asiaticoside and repamycin: A new hope for in-stent restenosis. Exp Ther Med. 6:557–561. 2013.PubMed/NCBI
27	Jiang PC, Xiong WP, Wang G, Ma C, Yao WQ, Kendell SF, Mehling BM, Yuan XH and Wu DC: A clinical trial report of autologous bone marrow-derived mesenchymal stem cell transplantation in patients with spinal cord injury. Exp Ther Med. 6:140–146. 2013.PubMed/NCBI
28	Rubio D, Garcia S, Paz MF, De la Cueva T, Lopez-Fernandez LA, Lloyd AC, Garcia-Castro J and Bernad A: Molecular characterization of spontaneous mesenchymal stem cell transformation. PLoS One. 3:e13982008. View Article : Google Scholar : PubMed/NCBI
29	de la Fuente R, Bernad A, Garcia-Castro J, Martin MC and Cigudosa JC: Retraction: Spontaneous human adult stem cell transformation. Cancer Res. 70:66822010. View Article : Google Scholar : PubMed/NCBI
30	Lin ZX and Xu H: Current understanding into the biological characteristics of mesenchymal stem cells. Zhongguo Zu Zhi Gong Cheng Yan Jiu Yu Lin Chuang Kang Fu. 15:3577–3580. 2011.(In Chinese).
31	Wang LZ, Xu L, Tan DM and Tan Y: The progress of survivin. Yi Xue Zong Shu. 12:1089–1092. 2006.(In Chinese).
32	Kobayashi M, Huang CL, Sonobe M, Kikuchi R, Ishikawa M, Kitamura J, Miyahara R, Menju T, Iwakiri S, Itoi K, Yasumizu R and Date H: Intratumoral Wnt2B expression affects tumor proliferation and survival in malignant pleural mesothelioma patients. Exp Ther Med. 3:952–958. 2012.PubMed/NCBI